Bharat Biotech has submitted phase 3 clinical trial application to DGCI for its booster dose of their intranasal Covid vaccine that can be given to Covaxin and Covishield vaccinated people: Source pic.twitter.com/Z7beF2i4PX— ANI (@ANI) December 20, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


